StockWatch
·
Commodity Chemicals
Board Meeting10 Aug 2026, 09:00 pm

Valiant Labs Approves Director Re-appointments, Office Shift, and ₹60 Cr Investment

AI Summary

Valiant Laboratories Limited announced key decisions from its Board of Directors meeting held on August 10, 2026. The board approved the re-appointment of Mr. Santosh Vora as Managing Director for five years and Mrs. Sonal Vira as Independent Director for a second five-year term. Continuation of Mr. Shantilal Vora's directorship was also recommended. The company will shift its registered office and open a new corporate office in Mumbai. Additionally, an investment of up to ₹60 Crore in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL), through Optionally Convertible Redeemable Preference Shares was approved. All re-appointments and the continuation of directorship are subject to member approval via Special Resolution at the upcoming AGM.

Key Highlights

  • Re-appointment of MD and Independent Director for five-year terms.
  • Approval for shifting registered office and opening a new corporate office.
  • Sanctioned investment of up to ₹60 Crore in subsidiary VASPL.
  • Director re-appointments require member approval via Special Resolution.